Over the past two decades, the biomedical R&D landscape has undergone a transformation, driven by a shift toward a patient-centric approach. Now, as patient engagement is expanding into medtech, digital health, and AI innovation, how can we leverage the patient experience to match the rapid pace of technological and regulatory evolution. This #MIHealthSummit session features a panel of experts exploring the current state of patient engagement, identify gaps, and offer actionable insights to optimize practices for the future. Watch the recording here: https://lnkd.in/ewexYb5K ??? Moderator: Marc Boutin, Former Pharmaceutical Executive and Patient Advocate Speakers Robyn Bent, Director, CDER Patient Focused Drug Development Program Ebony Dashiell-Aje, PhD-Aje, Executive Director, Head, Patient Centered Outcomes Science, BioMarin Pharmaceutical Inc. Andrea Ferris, President and CEO, LUNGevity Foundation Juan Garcia Burgos, Head of Public and Stakeholder Engagement, European Medicines Agency Beth Meagher, Vice Chair, US Federal Health Sector Leader, Deloitte
-
+2